Progressive Supranuclear Palsy is a class of neuro-degenerative disorder that affects movement, control of walking and balance, speech, swallowing, vision, mood and behavior, and thinking.
This report contains market size and forecasts of Progressive Supranuclear Palsy in Global, including the following market information:
Global Progressive Supranuclear Palsy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Progressive Supranuclear Palsy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Early Stage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Progressive Supranuclear Palsy include Merck & Co., Inc., Aton Pharma, Inc., Bristol Myers Squibb (BMS), GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries Ltd., AB Science, AbbVie Inc. and AlzProtect SAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Progressive Supranuclear Palsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Progressive Supranuclear Palsy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Progressive Supranuclear Palsy Market Segment Percentages, by Type, 2021 (%)
Early Stage
Clinical Trial
Late Stage
Others
Global Progressive Supranuclear Palsy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Progressive Supranuclear Palsy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research Institutes
Others
Global Progressive Supranuclear Palsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Progressive Supranuclear Palsy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Progressive Supranuclear Palsy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Progressive Supranuclear Palsy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
Aton Pharma, Inc.
Bristol Myers Squibb (BMS)
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries Ltd.
AB Science
AbbVie Inc.
AlzProtect SAS
Cortice Biosciences, Inc.
Acorda Therapeutics Inc.
Biogen Inc.